Cargando…

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six...

Descripción completa

Detalles Bibliográficos
Autores principales: Muecksch, Frauke, Weisblum, Yiska, Barnes, Christopher O., Schmidt, Fabian, Schaefer-Babajew, Dennis, Lorenzi, Julio C C, Flyak, Andrew I, DeLaitsch, Andrew T, Huey-Tubman, Kathryn E, Hou, Shurong, Schiffer, Celia A., Gaebler, Christian, Wang, Zijun, Da Silva, Justin, Poston, Daniel, Finkin, Shlomo, Cho, Alice, Cipolla, Melissa, Oliveira, Thiago Y., Millard, Katrina G., Ramos, Victor, Gazumyan, Anna, Rutkowska, Magdalena, Caskey, Marina, Nussenzweig, Michel C., Bjorkman, Pamela J., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987023/
https://www.ncbi.nlm.nih.gov/pubmed/33758864
http://dx.doi.org/10.1101/2021.03.07.434227
_version_ 1783668549993103360
author Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Lorenzi, Julio C C
Flyak, Andrew I
DeLaitsch, Andrew T
Huey-Tubman, Kathryn E
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Wang, Zijun
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
author_facet Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Lorenzi, Julio C C
Flyak, Andrew I
DeLaitsch, Andrew T
Huey-Tubman, Kathryn E
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Wang, Zijun
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
author_sort Muecksch, Frauke
collection PubMed
description Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.
format Online
Article
Text
id pubmed-7987023
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-79870232021-03-24 Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies Muecksch, Frauke Weisblum, Yiska Barnes, Christopher O. Schmidt, Fabian Schaefer-Babajew, Dennis Lorenzi, Julio C C Flyak, Andrew I DeLaitsch, Andrew T Huey-Tubman, Kathryn E Hou, Shurong Schiffer, Celia A. Gaebler, Christian Wang, Zijun Da Silva, Justin Poston, Daniel Finkin, Shlomo Cho, Alice Cipolla, Melissa Oliveira, Thiago Y. Millard, Katrina G. Ramos, Victor Gazumyan, Anna Rutkowska, Magdalena Caskey, Marina Nussenzweig, Michel C. Bjorkman, Pamela J. Hatziioannou, Theodora Bieniasz, Paul D. bioRxiv Article Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses. Cold Spring Harbor Laboratory 2021-03-08 /pmc/articles/PMC7987023/ /pubmed/33758864 http://dx.doi.org/10.1101/2021.03.07.434227 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Muecksch, Frauke
Weisblum, Yiska
Barnes, Christopher O.
Schmidt, Fabian
Schaefer-Babajew, Dennis
Lorenzi, Julio C C
Flyak, Andrew I
DeLaitsch, Andrew T
Huey-Tubman, Kathryn E
Hou, Shurong
Schiffer, Celia A.
Gaebler, Christian
Wang, Zijun
Da Silva, Justin
Poston, Daniel
Finkin, Shlomo
Cho, Alice
Cipolla, Melissa
Oliveira, Thiago Y.
Millard, Katrina G.
Ramos, Victor
Gazumyan, Anna
Rutkowska, Magdalena
Caskey, Marina
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Hatziioannou, Theodora
Bieniasz, Paul D.
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title_full Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title_fullStr Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title_full_unstemmed Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title_short Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
title_sort development of potency, breadth and resilience to viral escape mutations in sars-cov-2 neutralizing antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987023/
https://www.ncbi.nlm.nih.gov/pubmed/33758864
http://dx.doi.org/10.1101/2021.03.07.434227
work_keys_str_mv AT mueckschfrauke developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT weisblumyiska developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT barneschristophero developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT schmidtfabian developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT schaeferbabajewdennis developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT lorenzijuliocc developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT flyakandrewi developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT delaitschandrewt developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT hueytubmankathryne developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT houshurong developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT schifferceliaa developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT gaeblerchristian developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT wangzijun developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT dasilvajustin developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT postondaniel developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT finkinshlomo developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT choalice developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT cipollamelissa developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT oliveirathiagoy developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT millardkatrinag developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT ramosvictor developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT gazumyananna developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT rutkowskamagdalena developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT caskeymarina developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT nussenzweigmichelc developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT bjorkmanpamelaj developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT hatziioannoutheodora developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies
AT bieniaszpauld developmentofpotencybreadthandresiliencetoviralescapemutationsinsarscov2neutralizingantibodies